Join to View Full Profile
450 Brookline AveBoston, MA 02215
Phone+1 857-215-1781
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Paolo Tarantino, MD is an oncologist in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts.
Education & Training
University of Naples Faculty of MedicineClass of 2016
Certifications & Licensure
MA State Medical License 2024 - 2025
Publications & Presentations
PubMed
- Lessons From Taxanes Versus Eribulin for First-Line Metastatic Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer in the EMERALD Study.Tess A O'Meara, Paolo Tarantino
Journal of Clinical Oncology. 2025-04-10 - Effects of AKT Inhibitors for PIK3CA/AKT1/PTEN-Altered Advanced or Metastatic Breast Cancer: A Meta-Analysis of Randomized Clinical Trials.Francisco Cezar Aquino de Moraes, Vitor Kendi Tsuchiya Sano, Caroline R M Pereira, Estella Aparecida de Laia, Carlos Stecca
Clinical Breast Cancer. 2025-03-20 - Outcomes and treatment patterns for stage I human epidermal growth factor receptor 2-positive breast cancer in the Surveillance, Epidemiology, and End Results database...Adrienne G Waks, Paolo Tarantino, Emily L Chen, Rachel A Freedman, Nancy U Lin
Cancer. 2025-02-01
Press Mentions
Elacestrant Shows Greater Benefit in Endocrine-Sensitive Breast CancerFebruary 20th, 2025- FDA Approval Sets Up Face Off in Early-Stage Breast Cancer: Abemaciclib or Ribociclib?November 18th, 2024
- Oncology Drug Report 2024November 18th, 2024
- Join now to see all
